SyntheticMR
Returning to growth trajectories - SEB (SEB Research)
Following a change of analyst and ahead of the Q2 report, we make minor positive revisions to our 2022-2024 adj. EBIT estimates and reiterate our mid-point DCF of SEK 35 per share. Based on our understanding, the weak Q1 was largely, among other things, due to adverse effects from larger orders towards the end of the quarter and we thus expect q-o-q improvements in Q2. In our view, the medium- to long-term growth prospects remain intact.
SEB Research
This research has been commissioned by the company. Only for professional investors resident in EEA member states. Reports may not be distributed to the US or other jurisdictions where to do so would be unlawful. Please see the disclaimer tab for any details of investment banking services recently provided by SEB that could be considered relevant to the subject matter of this research.